Aarti Drugs Ltd
NSE:AARTIDRUGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aarti Drugs Ltd
NSE:AARTIDRUGS
|
IN |
|
Y
|
Yantai Eddie Precision Machinery Co Ltd
SSE:603638
|
CN |
|
Mobimo Holding AG
SIX:MOBN
|
CH |
|
Althea Group Holdings Ltd
ASX:AGH
|
AU |
|
Polarean Imaging PLC
LSE:POLX
|
US |
|
J
|
Japan Exchange Group Inc
F:OSK
|
JP |
|
Gujarat Gas Ltd
NSE:GUJGASLTD
|
IN |
Wall Street
Price Targets
AARTIDRUGS Price Targets Summary
Aarti Drugs Ltd
According to Wall Street analysts, the average 1-year price target for
AARTIDRUGS
is 489.6 INR
with a low forecast of 484.8 INR and a high forecast of 504 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AARTIDRUGS's stock price target?
Price Target
489.6
INR
According to Wall Street analysts, the average 1-year price target for
AARTIDRUGS
is 489.6 INR
with a low forecast of 484.8 INR and a high forecast of 504 INR.
What is Aarti Drugs Ltd's Revenue forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Aarti Drugs Ltd's revenue is
10%.
The projected
CAGR
for the next 3 years is
12%.
What is Aarti Drugs Ltd's Operating Income forecast?
Projected CAGR
19%
For the last 13 years the
compound annual growth rate for
Aarti Drugs Ltd's operating income is
12%.
The projected
CAGR
for the next 3 years is
19%.
What is Aarti Drugs Ltd's Net Income forecast?
Projected CAGR
17%
For the last 13 years the
compound annual growth rate for
Aarti Drugs Ltd's net income is
17%.
The projected
CAGR
for the next 3 years is
17%.
